MedTrace Logo

Retrospective Epidemiological Study of Locally Advanced Non Small Cell Lung Cancer Patients in Brazil

NCT03836469 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 403

Last updated 2024-02-20

No results posted yet for this study

Summary

RELANCE is a large multi-institutional study that aims to retrospectively collect information about diagnostic, treatment and outcome of patients diagnosed with locally advanced NSCLC in Brazil. It is hypothesized that there is a great heterogeneity in treatment patterns owing to inequities in access to adequate staging methods, optimal treatment and multidisciplinary teams in Brazil.

Conditions

  • Lung Cancer, Non-small Cell

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Latin American Cooperative Oncology Group

    lead OTHER

Principal Investigators

  • Vladmir Cláudio Cordeiro de Lima · Latin American Cooperative Oncology Group

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-25
Primary Completion
2022-06-09
Completion
2022-06-09

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03836469 on ClinicalTrials.gov